Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AtheroSclerotic Cardiovascular disEase Risk assessmenT and treAtment In AustraliaN Primary Care (VICTORION-ASCERTAIN: Implementation Study)

NCT05834673 is registered in ClinicalTrials.gov with Monash University as lead sponsor.

NCT NCT05834673
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05834673 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AtheroSclerotic Cardiovascular disEase Risk assessmenT and treAtment In AustraliaN Primary Care (VICTORION-ASCERTAIN: Implementation Study)
Lead sponsor
Monash University
Phase
Not applicable
Overall status
Terminated
Start date
November 17, 2023
Completion date
December 19, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerotic cardiovascular disease (ascvd), cerebrovascular disease, coronary heart disease (chd), peripheral arterial disease (pad)